Role of p21(Waf1/Cip1/Sdi1) in cell death and DNA repair as studied using a tetracycline-inducible system in p53-deficient cells

Oncogene

Volumn 14, Issue 15, 1997, Pages 1875-1882

  Sheikh, M Saeed ^a   Chen, Yong Q ^b   Smith, Martin L ^a   Fornace Jr , Albert J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adriamycin; Cell death; Excision repair; p53 deficient cells; U.v. irradiation

Indexed keywords

PROTEIN P21; PROTEIN P53; CDKN1A PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLINE; PROTEIN SYNTHESIS INHIBITOR; TETRACYCLINE;

APOPTOSIS; ARTICLE; CELL DEATH; COLORECTAL CARCINOMA; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; EXCISION REPAIR; GIANT CELL; HUMAN; HUMAN CELL; PHENOTYPE; PRIORITY JOURNAL; TRANSGENE; TUMOR SUPPRESSOR GENE; ULTRAVIOLET IRRADIATION; CELL CULTURE; COLORECTAL TUMOR; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; METABOLISM; PATHOLOGY; PHYSIOLOGY;

CELL DEATH; COLORECTAL NEOPLASMS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DNA REPAIR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; PROTEIN SYNTHESIS INHIBITORS; TETRACYCLINE; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0030612714     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1201004     Document Type: Article

References (42)

1. Attardi LD, Lowe S, Brugarolas J and Jacks T. (1996). EMBO J., 15, 3693-3701.
2. Blagosklonny MV, Schulte T, Nguyen P, Mimnaugh EG, Trepel J and Neckers LM. (1995). Cancer Res., 55, 4623-4626.
3. Blagosklonny MV, Schulte T, Nguyen P, Trepel J and Neckers LM. (1996). Cancer Res., 56, 1851-1854.
4. Chen YQ, Cipriano SC, Arenkiel JM and Miller FR. (1995). Cancer Res., 55, 4536-4539.
5. DiGuiseppe JA, Redston MS, Yeo CJ, Kern MS and Hruban RH. (1995). Am. J. Pathol., 147, 884-888.
6. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW and Vogelstein B. (1993). Cell, 75, 817-825.
7. El-Deiry WS, Harper WJ, O'Connor PM, Velculescu VE, Canman CE, Jackman J, Pietenpol JA, Burrell M, Hill DE, Wang Y, Wiman KG, Mercer WE, Kastan MB, Kohn KW, Elledge SJ, Kinzler KW and Vogelstein B. (1994). Cancer Res., 54, 1169-1174.
8. Friedberg EC, Walker GC and Siede W. (1995). DNA Repair and Mutagenesis, ASM Press: Washington, DC.
9. Gossen M and Bujard H. (1992). Proc. Natl. Acad. Sci. USA, 89, 5547-5551.
10. Harper JW, Adami GR, Wei N, Keyomarsi K and Elledge SJ. (1993). Cell, 75, 805-816.
11. Huang Y, Chan AM-L, Liu Y, Wang X and Holbrook NJ (Submitted for publication).
12. Isaac JT. (1994). Cur. Opin. Oncol., 6, 82-89.
13. Johnson EA, Davidson AG, Hostetter RB, Cook LL, Thomas EM and Quinlan DC. (1996). Proc. Amer. Assoc. Cancer Res., 37, 569.
14. Jung JM, Bruner JM. Ruan S, Langford LA, Kyrilsis AP, Kobayashi T, Levin VA and Zhang W. (1995). Oncogene, 11, 2021-2028.
15. Klocker H, Schneider R, Burtsher HJ, Aver B, Hirsch-Kaufmann M and Schweiger M. (1985). Eur. J. Cell. Biol., 39, 346-351.
16. Kobayashi T, Consoli U, Andreeff M, Shiku H, Deisseroth AB and Zhang W. (1995). Oncogene, 11, 2311-2316.
17. Li R, Waga S, Hannon GJ, Beach D and Stillman B. (1994). Nature, 371, 534-537.
18. Lin JK, Ho YS, Wang YJ and Lin-Shiau SY. (1996). Proc. Am. Assoc. Cancer Res., 37, 29.
19. McDonald III ER, Wu GS, Waldman T and ElDeiry WS. (1996). Cancer Res., 56, 2250-2255.
20. Michieli P, Chedid M, Lin D, Pierce JH, Mercer WE and Givol D. (1994). Cancer Res., 54, 3391-3395.
21. Noda A, Ning Y, Venable SF, Pereira-Smith OM and Smith JR. (1994). Exp. Cell Res., 211, 90-98.
22. Pan ZQ, Reardon JT, Li L, Flores-Rozas H, Legerski R, Sancar A and Hurwitz J. (1995). J. Biol. Chem., 270, 22008-22016.
23. Prabu NS, Blagosklonny MV, Zeng YX, Wu GS, Waldman T and ElDeiry WS. (1996). Clin. Cancer Res., 2, 1221-1229.
24. Protic M, Roilides E, Levine AS and Dixon K. (1988). Somat. Cell Mol. Genet., 14, 351-357.
25. Reed SI, Bailly E, Dulic V, Hengst L, Resnitzky D and Slingerland J. J. Cell Sci. (Suppl), 18, 69-73.
26. Sancar A. (1994). Science, 266, 1954-1956.
27. Shao Z-M, Dawson MI, Li X-S, Rishi AK, Sheikh MS, Han Q-X, Ordonez JV, Shroot B and Fontana JA. (1995). Oncogene, 11: 493-504.
28. Sheikh MS, Li XS, Chen JC, Shao ZM, Ordonez JV and Fontana JA. (1994). Oncogene, 9, 3407-3415.
29. Sheikh MS, Rochefort H and Garcia M. (1995). Oncogene, 11, 1899-1905.
30. Sheikh MS, Garcia M, Zhan Q, Liu Y and Fornace AJ Jr. (1996). Cell Growth & Diff., 7, 1599-1607.
31. Sherr CJ and Roberts JM. (1995). Genes & Dev., 9, 1149-1163.
32. Shivji MKK, Grey SJ, Strausfeld UP, Wood RD and Blow JJ. (1994). Curr. Biol., 4, 1062-1068.
33. Smith ML, Chen IT, Zhan Q, O'Connor PM and Fornace AJ Jr. (1995). Oncogene, 10, 1053-1059.
34. Smith ML, Kontny HU, Zhan Q, Sreenath A, O'Connor PM and Fornace AJ Jr. (1996). Oncogene, (in press).
35. Steinman RA, Hoffman B, Iro A, Guillouf C, Liebermann DA and El-Houseini ME. (1994). Oncogene, 9, 3389-3396.
36. Waldman T, Kinzler WK and Vogelstein B. (1995). Cancer Res., 55, 5187-5190.
37. Waldman T, Lengauer C, Kinzler WK and Vogelstein B. (1996). Nature, 381, 713-716.
38. Wang J and Walsh K. (1996). Science, 273, 359-361.
39. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R and Beach D. (1993). Nature, 366, 701-704.
40. Yang JL, Szak ST, Dixit M, Pietenpol JA and Arteaga CL. (1996). Proc. Am. Assoc. Cancer Res., 37, 593.
41. Zhang W, Ruan SB, Bruner JM, Fuller GN, Jung JM, Li H, Jabbur J, Kyritsis AP and Levin VA. (1996). Proc. Am. Assoc. Cancer Res., 37, 5.
42. Zhang W, Grasso L, McClain CD, Gambel AM, Cha Y, Travail S, Deisseroith AB and Mercer WE. (1995). Cancer Res., 55, 668-674.